Literature DB >> 7947251

Scedosporium inflatum infection in immunocompromised haematological patients.

M Tapia1, C Richard, J Baro, R Salesa, J Figols, F Zurbano, A Zubizarreta.   

Abstract

We report four cases of Scedosporium inflatum (S. inflatum) infection in severely immunocompromised haematological patients. Six well-documented cases of S. inflatum disseminated infection in haematological patients have been reported: four in Australia and two in Spain. Their clinical and pathological characteristics are heterogenous, particularly in the Australian cases. However, the clinical and pathological profile emerging from our and other Spanish cases is homogenous and very similar to the clinico-pathological spectrum of other disseminated mycoses, including Aspergillus and S. apiospermum. The optimal treatment of S. inflatum infection is unknown and the outcome in haematological patients is very poor. Eight patients died despite systemic antifungal treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947251     DOI: 10.1111/j.1365-2141.1994.tb04897.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.

Authors:  R San Millán; G Quindós; J Garaizar; R Salesa; J Guarro; J Pontón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Fatal Scedosporium prolificans infection in a leukemic patient.

Authors:  M C Feltkamp; M J Kersten; J van der Lelie; J D Burggraaf; G S de Hoog; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

3.  Scedosporium prolificans fungemia.

Authors:  S Elsayed; R Lannigan; I Chin-Yee
Journal:  Can J Infect Dis       Date:  1999-01

4.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 5.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.

Authors:  M Alvarez; B Lopez Ponga; C Rayon; J Garcia Gala; M C Roson Porto; M Gonzalez; J V Martinez-Suarez; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.

Authors:  Cristina Gil-Lamaignere; Emmanuel Roilides; Juan Mosquera; Avgi Maloukou; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

Review 8.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.

Authors:  William J Steinbach; Wiley A Schell; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.

Authors:  Laurence Delhaes; Azian Harun; Sharon C A Chen; Quoc Nguyen; Monica Slavin; Christopher H Heath; Krystyna Maszewska; Catriona Halliday; Vincent Robert; Tania C Sorrell; Wieland Meyer
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.